Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ovid Therapeutics Inc.

0.3096
+0.01093.65%
Pre-market: 0.31990.0103+3.33%09:04 EDT
Volume:2.01M
Turnover:604.62K
Market Cap:22.02M
PE:-0.90
High:0.3181
Open:0.3100
Low:0.2872
Close:0.2987
Loading ...

Ovid Therapeutics Inc. to Host Investor and Media Event on Emerging Epilepsy Biomarkers and OV329 Program Highlights

Reuters
·
1 hour ago

Ovid Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
13 May

Ovid Therapeutics Q1 EPS $(0.14), Inline, Sales $130.00K Beat $50.00K Estimate

Benzinga
·
13 May

BRIEF-Ovid Therapeutics Q1 Operating Expenses USD 12.68 Million

Reuters
·
13 May

Ovid Therapeutics Reports Q1 2025 Net Loss of $10.2M, EPS Improves to $0.14 as Revenues Slip to $130K

Reuters
·
13 May

Ovid Therapeutics Q1 Operating Expenses USD 12.68 Million

THOMSON REUTERS
·
13 May

Press Release: Ovid Therapeutics Reports Business Updates and First Quarter 2025 Financial Results

Dow Jones
·
13 May

Ovid Therapeutics Inc expected to post a loss of 14 cents a share - Earnings Preview

Reuters
·
09 May

Ovid Therapeutics Inc. : H.c. Wainwright Cuts Target Price to $2 From $3

THOMSON REUTERS
·
24 Mar

William Blair Sticks to Their Buy Rating for Ovid Therapeutics (OVID)

TIPRANKS
·
12 Mar

Ovid Therapeutics’ Cybersecurity Challenges: Navigating IT Risks and Third-Party Dependencies

TIPRANKS
·
12 Mar

Ovid Therapeutics (OVID) Reports Q4 Loss, Lags Revenue Estimates

Zacks
·
11 Mar

Ovid Therapeutics Q4 2024 GAAP EPS $(0.13) Beats $(0.16) Estimate, Sales $76K Miss $189.286K Estimate

Benzinga
·
11 Mar

Press Release: Ovid Therapeutics Reports Business Updates and Fourth Quarter and Full Year 2024 Financial Results

Dow Jones
·
11 Mar

We're A Little Worried About Ovid Therapeutics' (NASDAQ:OVID) Cash Burn Rate

Simply Wall St.
·
11 Mar

Ovid Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview

Reuters
·
04 Mar

BRIEF-Ovid Therapeutics Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos To Board Of Directors

Reuters
·
03 Mar

Ovid Therapeutics appoints Papadopoulos to board of directors

TIPRANKS
·
03 Mar

Ovid Therapeutics Appoints Pioneering Industry Leader DR. Stelios Papadopoulos to Board of Directors

THOMSON REUTERS
·
03 Mar

Ovid Therapeutics Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos to Board of Directors

GlobeNewswire
·
03 Mar